M
Mikhail A. Kutuzov
Researcher at Russian Academy of Sciences
Publications - 60
Citations - 2031
Mikhail A. Kutuzov is an academic researcher from Russian Academy of Sciences. The author has contributed to research in topics: Phosphatase & Protein phosphorylation. The author has an hindex of 25, co-authored 51 publications receiving 1821 citations. Previous affiliations of Mikhail A. Kutuzov include French Alternative Energies and Atomic Energy Commission & Oxford Brookes University.
Papers
More filters
Journal ArticleDOI
Vimentin regulates activation of the NLRP3 inflammasome
Gimena dos Santos,Micah R. Rogel,Margaret A. Baker,James R. Troken,Daniela Urich,Luisa Morales-Nebreda,Joseph A. Sennello,Mikhail A. Kutuzov,Albert Sitikov,Jennifer M. Davis,Anna P. Lam,Paul Cheresh,David W. Kamp,Dale K. Shumaker,G. R. Scott Budinger,Karen M. Ridge +15 more
TL;DR: It is demonstrated that central pathophysiologic events in ALI are attenuated in the lungs of Vim−/− mice challenged with LPS, bleomycin and asbestos and suggests that vimentin may be a key regulator of the NLRP3 inflammasome.
Journal ArticleDOI
Regulation of surfactant secretion in alveolar type II cells.
TL;DR: Signal transduction pathways involved in regulation of these processes are discussed as well as disorders associated with their malfunction, and lamellar bodies-independent secretion is also considered.
Journal ArticleDOI
The inflammasome in lung diseases.
TL;DR: The aim of this review is to summarize the most relevant points of inflammasome activation in lung diseases.
Journal ArticleDOI
Widespread presence of "bacterial-like" PPP phosphatases in eukaryotes
TL;DR: It is demonstrated that many eukaryotes possess diverse "bacterial-like" PPP phosphatases, the enzymatic characteristics, physiological roles and precise evolutionary history of which have yet to be determined.
Journal ArticleDOI
Cadherin 13 in cancer.
TL;DR: CDH13 re‐expression in most cancer cell lines inhibits cell proliferation and invasiveness, increases susceptibility to apoptosis, and reduces tumor growth in in vivo models, which suggest that CDH13 may represent a possible target for therapy in some cancers.